Revision of USP Chapter on IR Spectroscopy

Recommendation
11-13 November 2025
With Updates on the new ICH Q1 Guideline!
In the Pharmacopeial Forum No 39(2), the USP has published the draft for the revised General Chapter <854> on Mid-Infrared Spectroscopy. This draft is the second one and takes into consideration the comments sent to the USP.
Some acceptance criteria for some of the single validation parameters have been adapted in the validation of IR methods. Regarding accuracy, the recovery rate has been added to 95.0% - 105.0% for drug product assay.
Regarding precision, the relative standard deviation for repeatability is set as follows:
- Not more than 1.0% for APIs
- Not more than 2.0% for medicinal products
- Not more than 20.0% for impurities
And for intermediate precision:
- Not more than 1.0% for APIs
- Not more than 3.0% for medicinal products
- Not more than 25.0% for impurities
In addition to revised Chapter <854>, there will also be the new General USP Chapter <1854> which describes theory and practice of Mid Infrared Spectroscopy.
Both documents can be found on the Pharmacopeial Forum of the USP website.
Related GMP News
29.10.2025FDA Warning Letter: Missing Tests, Missing Proof
16.10.2025Shelf Life vs. Retest Date - What's the Difference?
08.10.2025FDA Warning Letter Highlights OOS Handling and Stability Failures
08.10.2025Pharmeuropa: Revision of Residual Solvents Chapter 2.4.24 Published for Comments
08.10.2025USP: Harmonized Chapter <701> Disintegration Adopted

